Pérez J, Rodríguez M J, Campaña O, Veiras S, Lorenzo D, Lamas M, Alvarez J
Servicio de Anestesia, Reanimación y Terapia del Dolor, Hospital Clínico Universitario de Santiago de Compostela.
Rev Esp Anestesiol Reanim. 2006 Nov;53(9):550-5.
The aim of this study was to describe our protocol for the anesthetic management for peritonectomy and hyperthermic intraperitoneal chemotherapy and to report the results from a series of 20 patients.
The patients were diagnosed with peritoneal carcinomatosis and classified ASA 1-3. A thoracic epidural catheter was inserted for invasive monitoring. We recorded duration of surgery, hemodynamic changes and the use of vasoconstrictors, requirement for intraoperative fluid replacement or blood product transfusion, diuresis, and use of diuretics.
Twenty patients were studied. Peritonectomy could not be performed in 3 patients and their data was excluded in order to avoid skewing. The mean (SD) duration of the intervention was 543 (98) minutes. Vasoconstrictors were used in 7 out of 17 patients (41%). Diuretics were used in 10 out of 17 patients (58%). Fluids infused during surgery were a mean of 7.9 (2) L of crystalloid solution and 2.3 (0.6) L of colloid solution. Packed red blood cells were transfused in 9 cases and only 1 patient required fresh frozen plasma. The temperature rose from 1-1.5 degrees C during administration of the hyperthermic chemotherapy and was controlled without complications with the infusion of cold liquids and a heating blanket set at 32-34 degrees C. Extubation inside the operating room was possible in 41% of the cases. Two patients developed postoperative respiratory problems and 1 patient, renal failure. One patient was reoperated for bleeding.
The described anesthetic management protocol allowed the intervention to be carried out without complications other than hypotension, which responded to vasoconstrictor therapy.
本研究旨在描述我们针对腹膜切除术和热灌注化疗的麻醉管理方案,并报告20例患者的系列研究结果。
患者被诊断为腹膜癌病,美国麻醉医师协会(ASA)分级为1-3级。插入胸段硬膜外导管进行有创监测。我们记录了手术时长、血流动力学变化及血管收缩剂的使用情况、术中液体补充或血液制品输注需求、尿量及利尿剂的使用情况。
共研究了20例患者。3例患者无法进行腹膜切除术,为避免数据偏差,其数据被排除。干预的平均(标准差)时长为543(98)分钟。17例患者中有7例(41%)使用了血管收缩剂。17例患者中有10例(58%)使用了利尿剂。手术期间输注的液体平均为7.9(2)L晶体溶液和2.3(0.6)L胶体溶液。9例患者输注了浓缩红细胞,仅1例患者需要新鲜冰冻血浆。在热灌注化疗期间,体温升高了1-1.5摄氏度,通过输注冷液体和将加热毯温度设置为32-34摄氏度,体温得到控制且无并发症。41%的病例在手术室即可拔管。2例患者出现术后呼吸问题,1例患者出现肾衰竭。1例患者因出血接受了再次手术。
所描述的麻醉管理方案使干预得以顺利进行,除低血压外无其他并发症,低血压对血管收缩剂治疗有效。